High-dose-rate brachytherapy at 3 Gy per fraction for lip carcinoma: Treatment outcomes and toxicity at 5-years.

Luboš Tuček,Igor Sirák,Miroslav Hodek,Linda Kašaová,Jakub Grepl,Petr Paluska,Denisa Pohanková,Libor Hruška,Milan Vošmik,Jiří Petera

Brachytherapy（2023）

引用 0|浏览6

暂无评分

摘要

These data support the use of HDR-BT for lip cancer. The dose and fractionation schedule used in this study (18 fractions x 3 Gy twice daily) seems to be effective and safe.

查看译文

关键词

Lip cancer,high-dose-rate brachytherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要